The Medicine Maker – Delivering Change
Summary: Alternative delivery routes for large-molecule drugs are sorely needed – could a new consortium lead the way? There has always been the need for greater collaboration between industry and academic partners. This article takes a closer look at an example of this collaboration in action – the Non-invasive Macromolecule Delivery Consortium (NMDC), spearheaded by the Catalent Applied Drug Delivery Institute. Here is what the experts are saying about NMDC and future of non-invasive delivery technologies for large molecules.